Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.3
Impact Factor 2024
1.5
CiteScore 2024
1.3
Impact Factor 2024
1.5
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs

    Catharina Margrethe Lerche, Hans Christian Wulf
    e13
    14-09-2010
    https://doi.org/10.4081/dr.2010.e13
    2112
    PDF: 833
    HTML: 171
  • Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

    Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi
    13-09-2023
    https://doi.org/10.4081/dr.2023.9839
    2636
    PDF: 963
    HTML: 27
  • Atopic dermatitis: a brief review of recent advances in its management

    Sultan Daghafak Alenazi
    23-05-2023
    https://doi.org/10.4081/dr.2023.9678
    2341
    PDF: 1384
    HTML: 97
  • Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

    Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    19-05-2023
    https://doi.org/10.4081/dr.2023.9692
    1039
    PDF: 522
    HTML: 17
  • Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

    Fitri Kadarsih Banjar, Farida Tabri, Sri Vitayani Muchtar, Mochammad Hatta, Khaeruddin Djawad, Farida Ilyas, Sitti Musafirah, Muhammad Nasrum Massi, Agussalim Bukhari, Andi Alfian Zainuddin
    12-09-2023
    https://doi.org/10.4081/dr.2023.9773
    899
    PDF: 448
    HTML: 15
  • Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

    Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    12-11-2024
    https://doi.org/10.4081/dr.2024.10080
    1102
    PDF: 610
    HTML: 25
  • Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI)

    Luca Fania, Cesare Massone, Francesco Cusano, Fabrizio Fantini, Elena Dellambra, Tonia Samela, Francesca Passarelli, Roberto Morese, Tommaso Tartaglione, Marino Maggiore, Piercarlo Gentile, Mattia Falchetto Osti, Francesca Sampogna, Sabatino Pallotta, Damiano Abeni, Paolo Marchetti, Luigi Naldi, ADOI steering group*
    05-08-2021
    https://doi.org/10.4081/dr.2021.9278
    3072
    PDF: 775
    HTML: 36
  • Effects of canary seed on two patients with disseminated granuloma annulare

    Lily Park, Claudia Green, Sergey Arutyunyan, Gabriella Vasile, Christopher Buckley, Eduardo Weiss
    23-12-2022
    https://doi.org/10.4081/dr.2023.9614
    1549
    PDF: 454
    HTML: 506
  • Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

    Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo
    30-05-2025
    https://doi.org/10.4081/dr.2025.10414
    528
    PDF: 319
    HTML: 2
  • Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

    Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole
    19-06-2023
    https://doi.org/10.4081/dr.2023.9755
    838
    PDF: 398
    HTML: 13
  • Refractory pityriasis rubra pilaris treated with abrocitinib

    Filip Rob
    09-01-2025
    https://doi.org/10.4081/dr.2025.10105
    373
    PDF: 249
    HTML: 9
  • New and emerging therapies in cutaneous T-cell lymphoma

    Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, Paolo Fava, Pietro Quaglino
    02-10-2024
    https://doi.org/10.4081/dr.2024.10002
    1030
    PDF: 553
    HTML: 91
  • Venous thromboembolism in bullous pemphigoid: current evidence from an updated systematic review

    Atheer G. Almutairi, Abeer G. Almutairi, Rahaf R. Almutairi, Asem Shadid, Alhanouf A. Bin Dakhil, Lamia Alakrash
    29-01-2025
    https://doi.org/10.4081/dr.2025.10257
    588
    PDF: 344
    SUPPLEMENTARY MATERIAL: 23
    HTML: 2
  • A microRNA focus on acne

    Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross
    02-02-2024
    https://doi.org/10.4081/dr.2024.9902
    1048
    PDF: 699
    HTML: 53
  • Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

    Anna Paola Lugli, Niccolò Gori, Elena Ippoliti, Benedetta Ambrosio, Ketty Peris
    03-02-2026
    https://doi.org/10.4081/dr.2026.10644
    435
    PDF: 201
  • Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

    Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota
    11-11-2024
    https://doi.org/10.4081/dr.2024.10140
    954
    PDF: 503
    SUPPLEMENTARY MATERIAL: 134
    HTML: 13
  • Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

    Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
    21-11-2022
    https://doi.org/10.4081/dr.2022.9447
    1284
    PDF: 389
    HTML: 42
  • Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

    Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
    17-03-2022
    https://doi.org/10.4081/dr.2022.9282
    1148
    PDF: 804
    HTML: 39
  • Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

    Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan
    21-11-2022
    https://doi.org/10.4081/dr.2022.9492
    1673
    PDF: 666
    HTML: 84
  • Telangiectasia Macularis Eruptiva Perstans: more than skin deep

    Casey E. Watkins, Winston B. Bokor, Stuart Leicht, George Youngberg, Guha Krishnaswamy
    e12
    29-07-2011
    https://doi.org/10.4081/dr.2011.e12
    11640
    PDF: 2189
    HTML: 2301
  • A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

    Vinh Ngo Minh, Thiên Phúc Lý, Hao Nguyen Trong, Chuong Nguyen Hoang
    12-04-2024
    https://doi.org/10.4081/dr.2024.9899
    950
    PDF: 549
    HTML: 23
  • Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

    Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili
    13-03-2025
    https://doi.org/10.4081/dr.2025.10021
    417
    PDF: 280
    HTML: 1
  • Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

    Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen
    11-10-2017
    https://doi.org/10.4081/dr.2017.7079
    1346
    PDF: 641
    HTML: 139
  • Psoriasiform eruption induced by dupilumab successfully treated with upadacitinib

    Mattia Minghini, Natale Schettini, Lucrezia Pacetti, Chiara Bocchi, Alessandro Borghi
    16-10-2025
    https://doi.org/10.4081/dr.2025.10588
    214
    PDF: 130
  • Flagellate dermatitis following consumption of shiitake mushroom

    Hui Voon Loo, Hazel H. Oon
    e21
    05-10-2011
    https://doi.org/10.4081/dr.2011.e21
    1647
    PDF: 806
    HTML: 1353
1 - 25 of 32 items 1 2 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy